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The interaction between a tandem repeat of the SPKK peptlde motif and calf thymus DNA or several polynucleotides has been investigated by 
circular dlchroism. The octapeptide SPKKSPKK does not Induce any Important changes in the CD spectra of the polynucleotldes 
poly(dG) poly(dC), poly(dG-dC) poly(dG-dC) and poly(dA) poly(dT) whde the spectrum of calf thymus DNA is slightly modified. Binding 
of this basic peptide to the alternating copolymer poly(dA-dT) poly(dA-dT) results m a marked Y-type condensation in a manner similar to that 
induced by the entire C-termmal domain of histone Hl. 
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1. INTRODUCTION 
Binding of histone proteins, more particularly histone 
Hl, to eukaryotic DNA has been shown as being one 
of the primary mechanisms by which transcription is 
controlled. Although the multiple roles of histones in 
transcription processes have been recently debated [ 1~ 
51, the precise nature of the molecular interactions be- 
tween histones and DNA remains to be clarified. It has 
been proposed that the histone Hl-DNA interaction 
implicates the DNA-binding peptide motif SPXX (X for 
a basic residue) [6,7]. Analogous basic peptides have 
been shown to be implicated in sequence-specific his- 
tone-DNA recognition processes [8,9]. Clustered S(T)- 
P-X-Basic motifs promote DNA-histone interactions 
[lo] and their phosphorylation [12,13] or acetylation 
[14] appear as many regulatory processes involved in 
chromatin condensation. 
ine-based DNA intercalating agent leads to a conjugate 
able to preferentially recognize AT-rich sites in DNA 
[16] with potential interest as antitumor agent [17]. In 
order to further delineate the ability of the S2 peptide to 
bind to DNA in a sequence-dependent manner, we have 
examined the S2 peptide-induced DNA conformational 
changes using the DNA from calf thymus (i.e. a natural 
DNA with random sequences) and four synthetic pol- 
ynucleotides with different base pair arrangements. The 
circular dichroism (CD) study reported here (i) provides 
further experimental evidence that the S, peptide does 
correspond to a sequence-selective DNA-binding motif, 
and (ii) shows that its binding is accompanied by a 
sequence-selective DNA condensation. Indeed, Y-type 
DNA condensations analogous to those described for 
much longer basic peptides [18.19] are detected when 
the peptide binds to the alternating copolymer poly(dA- 
dT) . poly(dA-dT). 
The octapeptide SPRKSPRK is found at the amino 
and carboxyl termini of histone Hl and the amino ter- 
minus of H2B from sea urchin sperm and binds selec- 
tively to AT-rich DNA sequences [6,8,15]. We have re- 
cently shown that the covalent linkage of the related 
octapeptide SPKKSPKK, called S? peptide, to an acrid- 
2. MATERIALS AND METHODS 
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The octapeptide SPKKSPKK was purchased commercially from 
Ntosystem SA (France). Its purity was checked by HPLC on a C,, 
column. Buffer A consisted of 0.1% aqueous trifluoroacetic acid. 
Buffer B contained 50% acetonitrile and 50% buffer A. The peptlde 
was eluted with a linear gradient of 040% buffer B over a period of 
20 min at a Aow rate of 1 mllmin (detection at 210 nm; peptide elution 
time 7 mm). The structure was analyzed by 400 MHz ‘H-NMR spec- 
troscopy and the FAB mass spectrum was also fully consistent with 
the expected structure [FAB: 899 (M’)]. No difference was observed 
with the SZ peptide prepared by a step-wise manual liquid-phase syn- 
thesis in accordance with the previously pubhshed procedure [17]. 
Abbreviations. CD, circular dichroism; CT, calf thymus; SPKK. Ser- 2.2. DNA and polwucleotides 
Pro-Lys-Lys; R. Arg; T, Thr. Calf thymus DNA (CT DNA, highly polymerized sodmm salt from 
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Sigma Chemical Co.) was deprotemized twtce with sodium dodecyl 
sulfate and prectpitated wtth ethanol. The final protem content was 
less than 0.2%. Polynucleotides poly(dA-dT) poly(dA-dT), poly(dG- 
dC) poly(dG-dC). poly(dA) poly(dT) and poly(dG) poly(dC) were 
purchased from Sigma. All the nucleic actda were extensively dialyzed 
agamst the dtchrotsm buffer (1 mM sodium cacodylate. pH 6.5) prior 
to measurements. Thetr concentrattons. expressed wtth respect to nu- 
cleottdes, were determined usmg extinctton coefficients (e) at 260 nm 
equal to 6,600. 6,600, 8.400, 6,000 and 7,400 Mm’ cm-‘, respectively 
PO]. 
CD spectra of DNA, polynucleottdes, peptide SZ and peptide-DNA 
complexes were recorded at 20°C in the UV regton (190-320 nm) on 
a Jobin-Yvon Mark V dichrograph interfaced to a microcomputer. 
Soluttons of peptide and/or nucleic acids m 1 mM sodium cacodylate 
buffer. pH 6 5 were scanned usmg l-cm pathlength quartz cuvettes 
Measurements were made by progressrve additton of the pepttde to a 
pure DNA (or polynucleotide) solutton at 100 PM to get the desired 
ligand/phosphate-DNA (L/P) ratto. The molar elhpttctty [8] was ex- 
pressed in deg cm’ dmol-’ per nucleottde. The CD spectra of the 
different homopolymers and alternating copolymers recorded under 
low ionic condtttons (1 mM sodmm tons) are m agreement with those 
reported m [20] obtamed at a htgher iomc strength (1 mM phosphate 
buffer contammg IO mM NaCl). 
3. RESULTS AND DISCUSSION 
The CD spectrum of the Sz peptide alone is character- 
ized by a negative band near 200 nm (Fig. 1; spectrum 
1). This feature has been found for other linear basic 
peptides such as the related octadecapeptide 
(KTPKKAKKP), from histone Hl and could reflect a 
potential organization of these motifs in p-turn struc- 
tures [l&21]. The S1 peptide alone presents no CD sig- 
nal in the 230-300 nm region so that the DNA structure 
can be characterized without interference from the pep- 
tide. 
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Ftg. 1. Cncular dichroism spectra of the complexes between the S1 
pepttde SPKKSPKK and the homopolymer poly(dA) poly(dT). 
Curve 1. S, peptide (50pM). Curve 2, poly(dA) poly(dT) (IOO~M). 
Curves 3 and 4. S2 peptIde_poly(dA) poly(dT) complexes at ligand 
to phosphate-DNA (L/P) molar ratios (L/P) of 0.2 and 0.6. respec- 
tively. All spectra were recorded m 1 mM sodium cacodylate buffer. 
pH 6.5. Molar elliptictties [@I for poly(dA) poly(dT) and SL pepttde 
are expressed m deg. cm’ dmolf per nucleottdc and ammo acrd 
residue. respectively. 
10 
05 
FIN. 2. Cncular drchroism spectra of the complexes between the S, 
pepttde and calf thymus DNA Curve 1. CT DNA (100pM). Curves 
2. 3 and 4. S, peptIde_calf thymus DNA complexes at hgand to phos- 
phate-DNA molar rattos of 0.4. 0.7 and 0.9. respectively. Molar elhp- 
ttctttes [@I are expressed m deg cm2 dmolf’ per nucleottde 
On adding the SZ peptide to the homopolynucleotide 
poly(dA) . poly(dT) (Fig. 1) only minor (if any) changes 
are observed within the wavelength region of 230-300 
nm. This directly implies that this homopolymer does 
not undergo any significant structural changes upon 
interacting with the peptide. This lack of effect must be 
related to the peculiar structural characteristics of this 
homopolymer. Indeed. poly(dA) . poly(dT) has long 
been known to be structurally distinct from random 
DNA sequences and can adopt more rigid and bent 
structures [22-241. The S, peptide is unable to overcome 
this rigidity and to alter significantly the homopolymer 
conformation. Consistent with our results are the obser- 
vations that long poly(dA) poly(dT) sequences cannot 
be reconstituted into nucleosome particles [25,26]. Sim- 
ilarly, the ellipticity remains unchanged when the S3 
peptide is added to a solution of the alternating copoly- 
mer poly(dG-dC) poly(dG-dC) or the homopolymer 
poly(dG) . poly(dC) (not shown). This is not surprising 
because footprinting studies with the S, peptide contain- 
ing six SPKK motifs [S] and the Sz peptide-acridine 
conjugate [16] have revealed that the basic motif does 
not bind to GC-rich sequences. 
Fig. 2 shows the CD spectra of CT DNA in the 
absence and presence of the S2 peptide. At a peptidel 
DNA ratio of 0.4 the spectra of the complex is shifted 
by about 5 nm with respect to that of CT DNA alone 
and a slight increase of both the negative band near 24.5 
nm and the positive one at 275 nm is observed (Fig. 3; 
spectrum 2). At higher molar ratios, the CD spectra of 
the S, peptide-CT DNA complexes are roughly similar 
to that obtained at a L/P ratio of 0.4; the positive and 
negative bands mentioned above are only slightly more 
182 
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Ftg. 3. Circular dichroism spectra of the complexes between the Sz 
pepttde and the alternating copolymer poly(dA-dT) poly(dA-dT). 
Curve 1 (a), poly(dA-dT) poly(dA-dT) (100 ,uM). Curves 2 (a). 3,4, 
5 and 6 (b), S2 peptide-poly(dA-dT) poly(dA-dT) complexes at ligand 
to phosphate-DNA molar ratios of 0.2. 0.4, 0 6, 0.8 and 1.0, respec- 
tively. 
intense (Fig. 2; spectra 3 and 4). The shape of these 
spectra are on the whole comparable to that of CT 
DNA alone thus showing that the conformation of CT 
DNA, though affected by the binding of the S2 peptide, 
has not been profoundly altered. From these CD spec- 
tra it is not possible to deduce any precise form adopted 
by the CT DNA but we can consider that the condensa- 
tion into Y-structures does not take place. It is worth 
noting here that minor spectral modifications have also 
been observed on adding the S3 peptide to DNAs from 
either Micrococcus Iysodeikticus (72% GC) or Clostrid- 
iztm perfringens (26% GC). The octapeptide has little 
effect on the structure of the three natural DNAs what- 
ever their AT/GC contents. 
The CD spectra of poly(dA-dT) poly(dA-dT) free 
and complexed with the octapeptide at different pep- 
tide/polynucleotide molar ratios are shown in Fig. 3. 
One can immediately observe that the octapeptide in- 
duces a packing arrangement of the DNA helices. At a 
L/P ratio of 0.2, the positive band at 265 nm disap- 
peared and a new positive one around 288 nm is ob- 
served (Fig. 3a; spectrum 2). This spectrum is reminis- 
cent of the one which characterizes the complex between 
poly(dA-dT) . poly(dA-dT) and poly-L-(Lys,-Ala), [27]. 
By analogy, it is plausible to believe that the peptide S2 
induces some kind of Y(+) supercoiled structure of the 
polynucleotide as does the polypeptide. These Y-DNA 
phases represent a particular state of DNA condensa- 
tion as found in liquid crystals [28] and exhibit charac- 
teristic CD spectra with maxima of negative or positive 
ellipticity corresponding to Y(-) and Y(+) forms, re- 
spectively. Y( -) phases are related to left-handedness in 
the intermolecular DNA helical arrangement and Y(+) 
to right-handedness [29,30]. At a peptide/polynucleotide 
ratio of 0.4, the CD spectrum of the complex is much 
higher in intensity than the one recorded at L/P ratio of 
0.2 and displays two positive maxima around 230 and 
285 nm and a negative one at 250 nm (Fig. 3b). The 
positive band around 290 nm is an order of magnitude 
higher than that observed at a L/P ratio of 0.2. This 
spectrum may reflect the presence of both Y(-) and 
Y( +) condensed DNA molecules. Subsequent addition 
of the peptide lead to a new category of CD signals 
attesting to the propagation of the condensation mech- 
anism. Indeed, at higher peptide concentrations, the 
spectra no longer exhibit the positive CD bands at 230 
and 285 nm and a single negative maximum takes place. 
A red-shift from 265 nm (L/P = 0.6) to 270 nm (L/ 
P = 1.0) occurs and the amplitude of the negative CD 
band is three- to four-fold higher than the one found at 
a L/P of 0.4 and lo-fold more intense than at a L/P ratio 
of 0.2. Therefore, Y(+)-DNA species are progressively 
converted into Y( -) structures upon further addition of 
the S, peptide. These structures are interconvertible and 
reversible, Y( -) being thermodynamically favoured as 
compared to Y(+) for the heteropolymer poly(dA- 
dT) . poly(dA-dT) [29]. At higher peptide/polynucleo- 
tide ratios (L/P > 1.0) the solutions become turbid be- 
cause of the precipitation of the peptide-DNA com- 
plexes. 
4. CONCLUSION 
Different significant conclusions can be drawn from 
the present CD study. First, the S, peptide can induce 
DNA condensation in a histone-like manner. Second, 
the effect is confined to alternating AT sequences since 
such a phenomenon was not detected with random 
DNA and the other polynucleotides. Thus, the S, pep- 
tide-induced condensation is sequence-selective and this 
has to be related to the sequence-selectivity of the DNA- 
binding motif SPKK previously shown by footprinting 
studies [8,16]. It is striking that the octapeptide does not 
bring about any Y-type condensation of calf thymus 
DNA and poly(dA) . poly(dT) contrarily to the histone 
H, peptide (KTPKKAKKP)? [18,19]. This may be rele- 
vant to the larger size and positive charge density of the 
latter peptide. Third, the study shows that the short 
octapeptide is sufficient to ensure the condensation of 
AT-rich DNA sequences as does the octadecapeptide 
(KTPKKAKKP), [19] or the entire C-terminal part of 
the histone H, [31]. This suggests that the S1 peptide 
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may correspond to a determinant motif implicated in 
the modulation of chromatin condensation and, as a 
consequence, in the regulation of the transcriptional 
machinery. Relevant to this, it will be of particular inter- 
est to study the effect of the acetylated or 
phosphorylated S2 peptides on DNA condensation. 
This should allow a better understanding of the molec- 
ular basis and physiological processes governing the 
interaction between DNA and SPXX motifs and thus 
chromatin condensation. 
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